Welcome to a pivotal moment in the global fight against infectious diseases. Today, we gather under the banner of the PATH Global Vaccine Research Collaboration at the prestigious G20 event to address the pressing need for collaboration, innovation, and solidarity in advancing vaccine research worldwide.

In the face of unprecedented challenges, our collective response is crucial to ensuring equitable access to life-saving vaccines and strengthening global health security. This event serves as a catalyst for fostering collaboration among G20 nations, bringing together experts, policymakers, and industry leaders who share a common vision: a world where everyone, regardless of their geographic location or socio-economic status, has access to effective vaccines.

The urgency of our mission cannot be overstated. The ongoing global health crisis underscores the importance of a unified approach to vaccine research and development. As we navigate these complex issues, the PATH Global Vaccine Research Collaboration stands at the forefront, committed to harnessing the collective expertise of G20 nations to accelerate breakthroughs, promote knowledge-sharing, and remove barriers hindering the global distribution of vaccines.

Throughout this event, we will explore innovative strategies, discuss collaborative initiatives, and forge partnerships that transcend borders and contribute to a safer and healthier world for all. The challenges ahead require us to think boldly, act decisively, and work together to build a sustainable framework for global vaccine research.

Thank you for joining us on this crucial journey. Together, we can turn the tide in the fight against infectious diseases and pave the way for a healthier, more resilient future.